In this study we describe the development of a novel human tumor antibody enhanced killing (TAEK) vaccine (VAC) encoding the membrane bound form of human CD40L, HER2 (Her) and the human transcription factor Brachyury (By), (TAEK-VAC-HerBy, TVH). This evidence concerns the gene ERBB2 and neoplasm.